SCHEMBL11922698

SCHEMBL11922698

CCc1c(C)cc(C(=O)NO)c(=O)n1Cc1ccc(F)c(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 9/20 0.54
CNR1 P21554 7/20 0.54
FAAH O00519 3/20 0.39
ALDH1A1 P00352 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
PDE10A Q9Y233 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5516297 0.91 CNR2 (0.54) CNR2CNR1FAAHALDH1A1PTGS1
SCHEMBL11922842 0.88 CNR2 (0.67) CNR2CNR1FAAHALDH1A1HDAC3
SCHEMBL5509594 0.88 CNR2 (0.54) CNR2CNR1FAAHALDH1A1PTGS1
SCHEMBL5508929 0.87 CNR2 (0.52) CNR2CNR1ALDH1A1PTGS1PTGS2
SCHEMBL11922694 0.81 CNR2 (0.51) CNR2CNR1ALDH1A1HDAC3HDAC4
SCHEMBL5514468 0.79 CNR2 (0.67) CNR2CNR1FAAHALDH1A1BRD4
SCHEMBL14472512 0.78 CNR2 (0.54) CNR2CNR1FAAHHDAC3HDAC4
SCHEMBL14865368 0.76 CNR2 (0.63) CNR2CNR1FAAHALDH1A1ABHD12
SCHEMBL5509529 0.76 CNR2 (0.66) CNR2CNR1FAAHABHD12
SCHEMBL5508310 0.75 CNR2 (0.54) CNR2CNR1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806342-B1 3-CARBAMOYL-2-PYRIDONE DERIVATIVE SHIONOGI & CO (JP) 2013-04-17 EP disclosed
US-20120208813-A1 3-CARBAMOYL-2-PYRIDONE DERIVATIVES SHIONOGI & CO., LTD. 2012-08-16 US disclosed
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative SHIONOGI & CO. LTD. (JP) 2008-05-01 US disclosed
EP-1806342-A1 3-CARBAMOYL-2-PYRIDONE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208813-A1 3-CARBAMOYL-2-PYRIDONE DERIVATIVES CNR2, CNR1, HRH4 CNR2 1/4885CNR1 2/4885FAAH 113/4885
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative CNR1, CNR2, HRH4 CNR2 2/4885CNR1 1/4885FAAH 146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.